Production Capacity
1 Operator 1 Shift 7,500 units PA
1 Operator 2 Shifts 15,000 units PA
External Dimensions
20ft x 8ft /6.1m x 2.4m
Internal Dimensions
18ft x 7ft /5.5m x 2.1m
Our COMPACT model is perfect for organizations with established storage and unboxing facilities, looking to seamlessly integrate the module with existing blood center component laboratories.
Production Capacity
1 Operator 1 Shift 7,500 units PA
1 Operator 2 Shifts 15,000 units PA
External Dimensions
20ft x 16ft /6.1m x 4.9m
Internal Dimensions
18ft x 15ft /5.5m x 4.6m
Our MAX model provides double the space with a double anteroom for unboxing, a separate changing area and clean storage vestibule. This is ideal for an organization that requires a full stand alone production facility.
Production Capacity
1 Operator 1 Shift 15,000 units PA
1 Operator 2 Shifts 30,000 units PA
External Dimensions
20ft x 24ft /6.1m x 7.3m
Internal Dimensions
18ft x 22ft /5.5m x 6.7m
Our ULTRA model provides 50% more space. A large anteroom for unboxing, a separate changing area, a clean storage vestibule, and double the production capacity of our COMPACT or MAX models. This is the perfect solution for an organization that requires a high capacity stand alone production facility.
Based on a standard shipping container, our veliPod range of Modular Spray Dried Plasma Labs offer potential solutions for rapid spray dried plasma production capability.
Each veliPod requires a separate clean, dry air system, which is also available as a containerized solution (AIRCUBE), to support Spray Dried Plasma production. veliPods can be customized to meet specific requirements, including additional building codes, compliance standards, accessibility needs, and certifications mandated by regional planning authorities, industry regulators, or institutional guidelines.
There are three standard layouts available, which can be used as designed or customized to meet your specific needs.
Introducing FrontlineODP™
Preventable death from hemorrhage following trauma is a global concern which has been targeted by trauma surgeons, emergency medical providers, mass casualty planners, the military and national governments as a top priority. Velico is proud to be developing the FrontlineODP™ Spray Dried Plasma System in support of this call to action.
FrontlineODP™ is a spray dried plasma unit designed for rapid rehydration, intended to support the management of traumatic hemorrhage in situations where conventional plasma is unavailable or impractical. This includes pre-hospital transfusions, rural and austere healthcare settings, and military applications.
This is our innovative solution…
The FrontlineODP™ Spray Dried Plasma System is being designed for easy integration in blood center component laboratories.
Decentralized production by blood centers will aim to take advantage of blood component manufacturing expertise and product supply chains, from established volunteer blood donor bases to end user distribution including emergency logistics channels.
Decentralized production sets the stage for local spray dried plasma self-suffciency and national emergency preparedness including civilian, government and military collaboration for strategic stockpiles and readiness for major mass casualty events.
Watch a video on our production process:
Engineered for remote locations
Customized to meet specific needs Supports highcapacity production
FrontlineODPTM System
Decentralized manufacturing
Integrates into blood bank labs Designed for ease of use and operation
FrontlineODPTM (On Demand Plasma)
Stability Targets
Why is it needed?
30-40 percent of deaths from bleeding are considered preventable. In the United States alone preventable death from bleeding takes over 30,000 lives per year with over 100,000 more estimated throughout the rest of the world †
A spray dried plasma solution has the potential to transform blood product distribution within the EMT community. Its extended shelf life could enable emergency vehicles to carry plasma for longer periods compared to whole blood or other alternatives, reducing the need for frequent replenishment.
Additionally, since spray dried plasma is designed for ambient storage, it offers a life-saving advantage in situations where emergency vehicles lack proper refrigeration but can maintain controlled ambient temperature conditions. This innovation could significantly enhance access to plasma in pre-hospital and remote emergency settings.
† Cannon JW. Hemorrhagic shock. N Engl J Med. 2018 Jan 25;378(4):370-9
VeliDryer
Our Model
Velico’s model is based on partnerships with regional blood centers which collect, test and manufacture life saving blood components every day. The FrontlineODP™ Spray Dried Plasma System is being designed for straightforward integration into existing blood component manufacturing centers without the need for specialized processing environments (e.g. clean rooms).
FrontlineODPTM Model
Military Usage
Velico Medical Inc.
• Manufactures Systems / Consumables
• Sells Systems / Consumables to military Bases
Military Bases/ Local Blood Centers
• Produces FrontlineODPTM
• Provides to Military Medical / Service Members
FrontlineODPTM (On Demand Plasma)
Intended Use
FrontlineODPTM has the potential to revolutionize emergency and prehospital care by:
• Expanding plasma accessibility for ground and air EMS teams
• Enhancing availability in rural and underserved areas
Rehydration
The FrontlineODP™ unit can be easily rehydrated in two and a half minutes with 200ml of sterile water (SWFI), making it practical in prehospital and hospital settings (i.e. rural) where fresh plasma is unavailable.
Watch a video on our rehydration process:
• Providing battlefield-ready plasma solutions for military use
• Strengthening mass casualty preparedness with regional stockpiles
Transfusion
Uncontrolled hemorrhage is recognized as the leading cause of preventable death among victims of trauma. The early administration of plasma has been demonstrated to be lifesaving for many of these patients †
† Sperry JL, et al. Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock. N Engl J Med. 2018 Jul 26;379(4):315-326
For
Richard Meehan, President & CEO
US: +1 (978) 338 4590
EU: +353 (86) 020 9272
rmeehan@veli.co
100 Cummings Center # 436H, Beverly, MA 01915, United States
+1 978 232 8370
Andre Cap, Chief Scientific Officer
US: +1 (210) 410 6882
acap@veli.co
5 Clarendon Mews, Lad Lane, Dublin 2, Ireland, D02 EE61 +353 1 2500 055
